IYÚ, D., GLENN, J.R., WHITE, A.E., JOHNSON, A., HEPTINSTALL, S. and FOX, S.C., 2012. The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function Thrombosis and Haemostasis. 107(4), 797-799 IYU, D., GLENN, J.R., WHITE, A.E., FOX, S.C. and HEPTINSTALL, S., 2011. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist Arteriosclerosis, Thrombosis and Vascular Biology. 31(2), 416-422 IYÚ, D., JÜTTNER, M., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2011. PGE1 and PGE2 modify platelet function through different prostanoid receptors Prostaglandins and Other Lipid Mediators. 94(1-2), 9-16 IYÚ, D., GLENN, J.R., WHITE, A.E., FOX, S.C., GIEZEN, H. VAN, NYLANDER, S. and HEPTINSTALL, S., 2011. Mode of action of P2Y12 antagonists as inhibitors of platelet function Thrombosis and Haemostasis. 105(1), 96-106 IYU, D., GLENN, J.R., WHITE, A.E., JOHNSON, A.J., FOX, S.C. and HEPTINSTALL, S., 2010. The role of prostanoid receptors in mediating the effects of PGE2 on human platelet function Platelets. 21(5), 329-342 HEPTINSTALL S, IYU D, MANOLOPOULOS P, GLENN JR, WHITE AE, JOHNSON A, DOVLATOVA N, FOX SC, MAY JA, HERMANN D and MAGNUSSON O, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
MAY JA, FOX SC, GLENN JR, CRAXFORD S and HEPTINSTALL S, 2008. Platelet function reduces significantly during the morning. Platelets. 19(7), 556-8
GLENN JR, WHITE AE, JOHNSON AJ, FOX SC, MYERS B and HEPTINSTALL S, 2008. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Platelets. 19(1), 59-69
MANOLOPOULOS, P., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N.L., TANG, S.-W., THOMAS, N.R., RALEVIC, V. and HEPTINSTALL, S., 2008. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents Platelets. 19(2), 134-145 HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and AND MYERS, B., 2007. Leucocytes influence platelet aggregation more than you think Platelets. 18(1), 77-78
WHITE AE, GLENN JR, FOX SC, JOHNSON A, MYERS B and HEPTINSTALL S, 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100
HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R and JOHNSON, A.J. AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Thrombosis Research. 120(Supplement 2), S153-S154
HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R, JOHNSON, A.J and AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-356
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 HEPTINSTALL, STAN, GLENN, JACQUELINE R, JOHNSON, ANDREW, MYERS, BETHAN, WHITE, ANN E and ZHAO, LIAN, 2006. Leukocytosis, vascular disease, and adenine nucleotide metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology. 26(2), e22-3 HEPTINSTALL, S., GLENN, J.R., JOHNSTON, A., WHITE, A. and MYERS, B., 2006. Leucocytes, leucocytosis and adenine nucleotide metabolism. Platelets. 17, 115
HEPTINSTALL, S., FOX, S.C., GLENN, J.R., JOHNSON, A., WHITE, A.E., DOLAN, G. and MYERS, B., 2006. Blood leucocytes are mobile modulators of adenine metabolism and play an important role in determining the effects of adenine nucleotides on platelet function. Purinergic Signalling. 2, 137
HEPTINSTALL, S., MANOLOPOULOS, M., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N., TANG, S-W., BAUER, N., HESSE, M., THOMAS, N.R. and RALEVIC, V., 2006. Acyl derivatives of coenzyme A inhibit ADP-induced platelet function via antagonism at P2Y1 and P2Y12 receptors. Purinergic Signalling. 2, 92-93
HEPTINSTALL,S., TANG,S., MANOLOPOULOS,P., FOX,S., MAY,J., GLENN,J. and RALEVIC,V., 2005. Derivatives of coenzymes A inhibit platelet aggregation via efects at P2Y1 and P2Y12 receptors. In: 20th Congress of the International Society on Thrombosis & Haemostasis. OR334
GLENN, J.R., WHITE, A.E., JOHNSON, A., FOX, S. and BEHAN, M.W., 2005. Raised blood leukocyte counts markedly alter platelet aggregation extent induced by ADP and ATP via CD39. In: International Society of Thrombosis and Haemostasis, Sydney Aug 2005. PO942